France’s Sanofi eyes rising earnings in 2022 after Q4 earnings increase By Reuters

February 4, 2022 admin Stock News 0

© Reuters. FILE PHOTO: A woman, wearing a protective face mask, walks past the logo of Sanofi at the company’s headquarters in Paris, France, January 31, 2022. REUTERS/Violeta Santos Moura

PARIS (Reuters) – French drugmaker Sanofi (NASDAQ:) said it would aim to further increase its earnings per share (EPS) this year as it reported rising fourth-quarter results on Friday.

The group, which is hoping for a comeback after losing ground in the COVID-19 jab race, is eyeing an increase in its EPS in the “low double-digit” in 2022.

Its sales in the three months to December grew 4.1% to 9.99 billion euros ($11.45 billion) while its EPS came in at 1.38 euros.

For the whole of 2021, its earnings per share rose by 15.5% at constant exchange rates, while the company had guided for a rise of 14%.

($1 = 0.8725 euros)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*